Human Clinical Research
Betterdays conducts structured human clinical research to evaluate product safety, tolerability, and health outcomes.
Why Betterdays Conducts In-Vivo Human Clinical Studies
The health supplement industry often relies on in-vitro tube assays or unverified claims. Betterdays focuses on direct human clinical evaluation.
Every Betterdays formulation is evaluated directly in human participants (in-vivo) to observe blood glucose dynamics, cellular insulin response, and tolerability profiles.
Evidence-Based Research Principles
- ✔ In-Vivo Human Testing: Validating biological mechanisms in human participants.
- ✔ Full Data Transparency: Open reporting of primary & secondary metrics.
- ✔ Continuous Research: Longitudinal study commitments for future formulas.
Completed Clinical Study (BD-CT-2025-01)
Explore the complete 90-day open-label clinical study on Triple Bioactive Peptides.
90-Day Open-Label Clinical Evaluation of BETTERDAYS Triple Bioactive Peptide Formulation on Glycemic Control, HbA1c Reduction, and Insulin Sensitivity in Adults
A 90-day controlled clinical study evaluating the efficacy of Triple Vegetarian Bioactive Peptides (Bitter Melon, Walnut, and Soy Oligopeptides) in regulating fasting glucose, reducing HbA1c, and supporting vascular health.
Betterdays Clinical Research Principles
Our core commitments to bioethical standards, scientific integrity, and open data reporting across all research phases.
Rigorous Scientific Methodology
All clinical trials follow structured bioethical protocols, observing subject safety and tracking laboratory metrics consistently.
Voluntary Informed Consent
Participation is voluntary under written informed consent with complete priority on subject wellbeing and privacy.
Transparent Data Presentation
We present clinical study metrics transparently without selective bias or data manipulation.
Continuous Evidence Generation
Scientific inquiry is an ongoing journey. We maintain an active clinical research pipeline to advance future bio-nutritional formulations.
Ongoing & Future Clinical Pipeline
Betterdays research architecture is designed to support ongoing and future study profiles seamlessly.
Randomized Double-Blind Placebo-Controlled Evaluation of VascularGuard™ on Endothelial Function & Microvascular Elasticity
Next-phase evaluation assessing the impact of bioactive synergy on Pulse Wave Velocity and microvascular circulation in adults.
Multi-Center Study on Bioactive Peptides for Post-Exercise Muscle Glycogen Resynthesis & Metabolic Recovery
Advanced research examining cellular glucose uptake in active individuals to accelerate physical recovery post-exercise.
Explore Scientific Evidence & Real-World Outcomes
Combine insights from Controlled Clinical Trials, Real-World Outcomes Registry, and Ingredient Study Journals for a complete scientific perspective.
